Deals in Oncology Personalized Medicine Industry – Worldwide Analysis
The Personalized Medicine in Oncology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the world’s leading healthcare companies in oncology sector. All the deals have been tracked year wise. All the deals have been covered under different chapters in below mentioned topics.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
- Collaboration Deals (Chapter No. 2.1)
- Partnership Deals (Chapter No. 2.2)
- Distribution Agreement Deals (Chapter No. 2.3)
- Joint Venture Deals (Chapter No. 2.4)
- Licensing Agreement Deals (Chapter No. 2.5)
- Strategic Alliances Deals (Chapter No. 2.6)
- Merger & Acquisition Deals (Chapter No. 2.7)
- Co–Promotion Deals (Chapter No. 2.8)
- Co–Marketing Deals (Chapter No. 2.9)
- Co–Development Deals (Chapter No. 2.10)
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
1. EXECUTIVE SUMMARY
2. DEALS TYPE IN ONCOLOGY PERSONALIZED MEDICINE
2.1 Collaboration Deals in Oncology Personalized Medicine
2.1.1 Year 2011
2.1.2 Year 2012
2.1.3 Year 2013
2.1.4 Year 2014
2.2 Partnership Deals in Oncology Personalized Medicine
2.2.1 Year 2007
2.2.2 Year 2011
2.2.3 Year 2013
2.2.4 Year 2014
2.3 Distribution Agreement Deals in Oncology Personalized Medicine
2.3.1 Year 2007
2.3.2 Year 2009
2.3.3 Year 2010
2.3.4 Year 2012
2.3.5 Year 2013
2.3.6 Year 2014
2.4 Joint Venture Deals in Oncology Personalized Medicine
2.4.1 Year 2012
2.4.2 Year 2013
2.5 Licensing Agreement Deals in Oncology Personalized Medicine
2.5.1 Year 2008
2.5.2 Year 2011
2.5.3 Year 2013
2.6 Strategic Alliances Deals in Oncology Personalized Medicine
2.6.1 Year 2011
2.6.2 Year 2013
2.7 Merger & Acquisition Deals in Oncology Personalized Medicine
2.7.1 Year 2013
2.8 Co–Promotion Deals in Oncology Personalized Medicine
2.8.1 Year 2011
2.8.2 Year 2012
2.9 Co–Marketing Deals in Oncology Personalized Medicine
2.9.1 Year 2012
2.9.2 Year 2013
2.10 Co–Development Deals in Oncology Personalized Medicine
2.10.1 Year 2011
2.10.2 Year 2013
2. DEALS TYPE IN ONCOLOGY PERSONALIZED MEDICINE
2.1 Collaboration Deals in Oncology Personalized Medicine
2.1.1 Year 2011
2.1.2 Year 2012
2.1.3 Year 2013
2.1.4 Year 2014
2.2 Partnership Deals in Oncology Personalized Medicine
2.2.1 Year 2007
2.2.2 Year 2011
2.2.3 Year 2013
2.2.4 Year 2014
2.3 Distribution Agreement Deals in Oncology Personalized Medicine
2.3.1 Year 2007
2.3.2 Year 2009
2.3.3 Year 2010
2.3.4 Year 2012
2.3.5 Year 2013
2.3.6 Year 2014
2.4 Joint Venture Deals in Oncology Personalized Medicine
2.4.1 Year 2012
2.4.2 Year 2013
2.5 Licensing Agreement Deals in Oncology Personalized Medicine
2.5.1 Year 2008
2.5.2 Year 2011
2.5.3 Year 2013
2.6 Strategic Alliances Deals in Oncology Personalized Medicine
2.6.1 Year 2011
2.6.2 Year 2013
2.7 Merger & Acquisition Deals in Oncology Personalized Medicine
2.7.1 Year 2013
2.8 Co–Promotion Deals in Oncology Personalized Medicine
2.8.1 Year 2011
2.8.2 Year 2012
2.9 Co–Marketing Deals in Oncology Personalized Medicine
2.9.1 Year 2012
2.9.2 Year 2013
2.10 Co–Development Deals in Oncology Personalized Medicine
2.10.1 Year 2011
2.10.2 Year 2013
LIST OF TABLES:
Table 1–1: Collaboration Deals in Oncology Personalized Medicine, 2011 – 2014
Table 1–2: Partnership Deals in Oncology Personalized Medicine, 2007 – 2014
Table 1–3: Distribution Agreement in Oncology Personalized Medicine, 2007 – 2014
Table 1–4: Joint Venture Deals in Oncology Personalized Medicine, 2012 – 2013
Table 1–5: Licensing Agreement in Oncology Personalized Medicine, 2008 – 2013
Table 1–6: Strategic Alliances in Oncology Personalized Medicine, 2011 – 2013
Table 1–7: Merger & Acquisition in Oncology Personalized Medicine, 2013
Table 1–8: Co–Promotion Deals in Oncology Personalized Medicine, 2011 – 2012
Table 1–9: Co–Marketing Deals in Oncology Personalized Medicine, 2012 – 2013
Table 1–10: Co–Development Deals in Oncology Personalized Medicine, 2011 – 2013
Table 1–1: Collaboration Deals in Oncology Personalized Medicine, 2011 – 2014
Table 1–2: Partnership Deals in Oncology Personalized Medicine, 2007 – 2014
Table 1–3: Distribution Agreement in Oncology Personalized Medicine, 2007 – 2014
Table 1–4: Joint Venture Deals in Oncology Personalized Medicine, 2012 – 2013
Table 1–5: Licensing Agreement in Oncology Personalized Medicine, 2008 – 2013
Table 1–6: Strategic Alliances in Oncology Personalized Medicine, 2011 – 2013
Table 1–7: Merger & Acquisition in Oncology Personalized Medicine, 2013
Table 1–8: Co–Promotion Deals in Oncology Personalized Medicine, 2011 – 2012
Table 1–9: Co–Marketing Deals in Oncology Personalized Medicine, 2012 – 2013
Table 1–10: Co–Development Deals in Oncology Personalized Medicine, 2011 – 2013
